In this episode, Blake speaks with Michelle Shogren, Senior Director of Innovation at Bayer, about how incorporating the patient experience in decentralized models breathes innovation into clinical trials.

Considering the Patient Experience in Decentralized Trials

The clinical research industry is changing at a rapid pace, and with good reason. Considering the gaps and issues exposed by the COVID-19 crisis, successful sites, sponsors and CROs recognize that it’s time for The Next Phase with a move toward a new, nimbler era of clinical research. Hosted by the remote site monitoring experts from Florence Healthcare, this podcast explores the new tools and practices that will better allow us to advance human health today and beyond.

Share Considering the Patient Experience in Decentralized Trials

Sign up to save your podcasts

Considering the Patient Experience in Decentralized Trials

Considering the Patient Experience in Decentralized Trials